Impact of immunosuppressive treatment on the immunogenicity of mRNA COVID-19 vaccine in vulnerable patients with giant cell arteritis.

Authors :: Delvino P
Bartoletti A
Cassaniti I
Bergami F
Lilleri D
Baldanti F
Bozzalla Cassione E
Biglia A
Montecucco C
Monti S
Source :: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2022 Feb 02; Vol. 61 (2), pp. 870-872.
Publication Year :: 2022

Subjects :: Aged
COVID-19 prevention & control
Female
Humans
Male
Pandemics
COVID-19 Vaccines immunology
Giant Cell Arteritis drug therapy
Immunogenicity, Vaccine immunology
Immunosuppressive Agents therapeutic use

Full Text Access

Tools